Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

GeoVax Reports Interim Data From Phase 2 Clinical Trial Of GEO-CM04S1 As Universal Covid-19 Vaccine Booster

Author: Benzinga Newsdesk | February 06, 2024 10:02am
  • Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants

Posted In: GOVX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist